Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc.

NASDAQ:PYXS

Overview | Financials
Company Name Pyxis Oncology, Inc.
Symbol PYXS
Currency USD
Price 3.66
Market Cap 217,487,971
Dividend Yield 0%
52-week-range 1.35 - 6.85
Industry Biotechnology
Sector Healthcare
CEO Dr. Lara S. Sullivan M.D., MBA
Website https://www.pyxisoncology.com

An error occurred while fetching data.

About Pyxis Oncology, Inc.

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC),

Related Stocks

Exagen Inc. logo

Exagen Inc.

XGN

2.84 USD

Longboard Pharmaceuticals, Inc. logo

Longboard Pharmaceuticals, Inc.

LBPH

29.31 USD

Financials

Numbers are in millions USD

Numbers are in millions USD